# US 2016/0354469 A1 · Composition, its preparation and method of use in treating skin disorders

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2016/0354469 A1
- Document ID: US20160354469A1
- Status: Published application
- Kind: A1
- Application number: 14/999,576
- Filed: 2016-05-26
- Published: 2016-12-08
- Earliest claimed: 2015-05-29
- Assignees: Accolade Pharma LLC
- Applicants: Accolade Pharma LLC
- Inventors: Amey Mahajan
- Web page: https://patentgrep.com/patent/US20160354469A1

## CPC

- A61K 47/10: Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
- A61K 9/0014: {Skin, i.e. galenical aspects of topical compositions (non-active ingredients are additionally classified in A61K47/00; A61K9/0009, A61K9/0021, A61K9/7015, A61K9/7023 take precedence; cosmetic preparations A61K8/00, A61Q; preparations for wound dressings or bandages A61L26/00)}
- A61K 9/06: Ointments; Bases therefor; {Other semi-solid forms, e.g. creams, sticks, gels (composition of ointments, creams or gels A61K47/00)}
- A61K 31/404: Indoles, e.g. pindolol
- A61K 47/14: Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

This invention pertains to a zafirlukast-containing composition, a method of preparing the composition, and a method for treating certain skin disorders using the zafirlukast-containing composition.

## Claims

### Claim 1

A composition comprising:
a. zafirlukast;
b. a first and a second polyethylene glycol;
c. a nonionic hydrophilic ester;
d. an alcohol; and
e. an antioxidant.

### Claim 2 (depends on 1)

The composition of claim 1, wherein the first polyethylene glycol is polyethylene glycol 400.

### Claim 3 (depends on 1)

The composition of claim 1, wherein the second polyethylene glycol is polyethylene glycol 1450.

### Claim 4 (depends on 1)

The composition of claim 1, where the nonionic hydrophilic ester is PEG 6 caprylic/capric glycerides.

### Claim 5 (depends on 1)

The composition of claim 1, where in the alcohol is stearyl alcohol.

### Claim 6 (depends on 1)

The composition of claim 1, wherein the antioxidant is selected from the group consisting of butylated hydroxytoluene, tent-butyl hydroquinone, butylated hydroxy anisole, and propyl gallate.

### Claim 7 (depends on 6)

The composition of claim 6, wherein the antioxidant is butylated hydroxytoluene.

### Claim 8 (depends on 1)

The composition of claim 1, wherein zafirlukast comprises 0.1-1 weight percent of the composition, the first polyethylene glycol comprises 50-65 weight percent of the composition, the nonionic hydrophilic ester comprises 4-5 weight percent of the composition, the second polyethylene glycol comprises 24-35 weight percent of the composition, the alcohol comprises 2-8 weight percent of the composition, and the antioxidant comprises 0.001-0.02 weight percent of the composition.

### Claim 9 (depends on 1)

The composition of claim 1, further comprising additional active agents, excipients, solvents, emulsifiers, chelating agents, surfactants, emollients, permeation enhancers, preservatives, lubricants, pH adjusters, adjuvants, dyes, or perfumes.

### Claim 10

A method for treating skin disorders comprising administering to a patient in need of treatment a composition comprising:
a. zafirlukast;
b. a first and a second polyethylene glycol;
c. a nonionic hydrophilic ester;
d. an alcohol; and
e. an antioxidant.

### Claim 11 (depends on 10)

The method of claim 10, wherein the skin disorder is selected from the group consisting of acne vulgaris, acne rosacea, acne conglobata, hidrandenitis suppurative, atopic dermatitis, chronic idiopathic urticaria, eczema, burns, sunburn and radiation burns.

### Claim 12 (depends on 10)

The method of claim 10, wherein the composition is applied to an area affected by the skin disorder once or multiple times per week.

### Claim 13 (depends on 10)

The method of claim 10, wherein the composition is applied one or more times per day.

### Claim 14 (depends on 10)

The method of claim 10, wherein the composition is a zafirlukast-containing ointment.

### Claim 15

A method for preparing a composition, comprising:
a. forming a first mixture by dissolving zafirlukast in a mixture of a nonionic hydrophilic ester and a first polyethylene glycol;
b. forming a melted phase by heating a mixture comprising the first polyethylene glycol, a second polyethylene glycol, and an alcohol;
c. dissolving an antioxidant in the melted phase to form a third mixture;
d. adding the first mixture to the third mixture while agitating; and
e. cooling the combined first and third mixture while maintaining agitation.

### Claim 16 (depends on 15)

The method of claim 15, wherein the composition is a zafirlukast-containing ointment.
